IGF1 as a Potential Treatment for Rett Syndrome: Safety Assessment in Six Rett Patients
Figure 1
IGF1 serum levels during the treatment. IGF1 levels in the blood were tested at each hospitalization: D0 (first day of treatment, before IGF administration), D90 (90 days after the first IGF1 administration), D180 (180 days after the first IGF administration, last day of IGF1 treatment), D270 (270 days after the first IGF administration), and D365 (365 days after the first IGF administration). The dotted lines represent the normal range of IGF1 in each patient. The amount of IGF1 is expressed in ng/mL and reported for each patient, and it is color-coded: S1: blue, S2: red, S3: green, S4: purple, S5: cyan, and S6: orange. The data for S6 at D270 is not available. The serum levels of IGF1 rose for each patient during the treatment and returned back to control levels after the end of the treatment.
